Implementing a randomised controlled trial through community pharmacies to support people living with severe and persistent mental illness: Lessons learnt during the COVID-19 pandemic

Commonwealth of Australia, 2020 Gillard, 2021, Experiences of living with mental health problems during the COVID-19 pandemic in the UK: a coproduced, participatory qualitative interview study, Soc. Psychiatry Psychiatr. Epidemiol., 56, 1447, 10.1007/s00127-021-02051-7 Van Rheenen, 2020, Mental health status of individuals with a mood-disorder during the COVID-19 pandemic in Australia: initial results from the COLLATE project, J. Affect. Disord., 275, 69, 10.1016/j.jad.2020.06.037 Sheridan Rains, 2021, Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: framework synthesis of international experiences and responses, Soc. Psychiatry Psychiatr. Epidemiol., 56, 13, 10.1007/s00127-020-01924-7 Murphy, 2021, The impact of the COVID-19 pandemic and its related restrictions on people with pre-existent mental health conditions: a scoping review, Arch. Psychiatr. Nurs., 35, 375, 10.1016/j.apnu.2021.05.002 World Health Organisation Heron, 2022, Loneliness among people with severe mental illness during the COVID-19 pandemic: results from a linked UK population cohort study, PLoS One, 17, 10.1371/journal.pone.0262363 Fleming, 2020, Conducting Clinical research during the COVID-19 pandemic: protecting scientific integrity, JAMA., 324, 33, 10.1001/jama.2020.9286 Sohrabi, 2021, Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - a review, Int. J. Surg., 86, 57, 10.1016/j.ijsu.2020.12.008 McDermott, 2020, Preserving Clinical trial integrity during the coronavirus pandemic, JAMA, 323, 2135, 10.1001/jama.2020.4689 Wheeler, 2020, Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial, BMJ Open, 10, 10.1136/bmjopen-2020-039983 Australian and New Zealand Clinical Trials Registry, 2022 Tremblay, 2021, Conducting qualitative research to respond to COVID-19 challenges: reflections for the present and beyond, Int J Qual Methods, 20, 10.1177/16094069211009679 Howlett, 2022, Looking at the ‘field’ through a zoom lens: methodological reflections on conducting online research during a global pandemic, Qual. Res., 22, 387, 10.1177/1468794120985691 Orkin, 2021, Guidelines for reporting trial protocols and completed Trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement, JAMA., 326, 257, 10.1001/jama.2021.9941 McMillan, 2022, A training programme for community pharmacists to support people living with severe and persistent mental illness: intervention mapping in the context of a pandemic, Health Educ. J., 81, 964, 10.1177/00178969221130461 Boukouvalas, 2020, Exploring health care professionals’ knowledge of, attitudes towards, and confidence in caring for people at risk of suicide: a systematic review, Arch Suicide Res., 24, S1, 10.1080/13811118.2019.1586608 O’Reilly, 2015, Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia, Res. Soc. Adm. Pharm., 11 Boukouvalas, 2018, Confidence and attitudes of pharmacy students towards mental health crises: patient simulation using people with a lived experience, Soc. Psychiatry Psychiatr. Epidemiol., 53, 1185, 10.1007/s00127-018-1582-2 Wheeler, 2014, Education and training for community pharmacists in mental health practice: how to equip this workforce for the future, J Mental Health Training Educ Pract., 9 Johnston, 2022, The experiences of pharmacists during the global COVID-19 pandemic: a thematic analysis using the jobs demands-resources framework, Res Social Adm Pharm, 18, 3649, 10.1016/j.sapharm.2022.03.018 Johnston, 2003, The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis, J. Am. Pharm. Assoc., 2022 Johnston, 2021, Burnout and the challenges facing pharmacists during COVID-19: results of a national survey, Int. J. Clin. Pharm., 43, 716, 10.1007/s11096-021-01268-5 Elbeddini, 2020, Mental health issues impacting pharmacists during COVID-19, J Pharm Policy and Pract., 13, 46, 10.1186/s40545-020-00252-0 Parajuli, 2022, Pharmacy practice in emergency response during the COVID-19 pandemic: lessons from Australia, Res Social Adm Pharm., 18, 3453, 10.1016/j.sapharm.2021.08.013 Commonwealth of Australia Department of Health and Aged Care Kessler, 2002, Short screening scales to monitor population prevalences and trends in non-specific psychological distress, Psychol. Med., 32, 959, 10.1017/S0033291702006074 Mansfield, 2021, Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study, Lancet Digit Health, 3, E217, 10.1016/S2589-7500(21)00017-0 Parkinson, 2022, The impact of COVID-19 on chronic disease management in primary care: lessons for Australia from the international experience, Med. J. Aust., 216, 445, 10.5694/mja2.51497